4//SEC Filing
Stern Lawrence D 4
Accession 0001225208-10-009458
CIK 0001405197other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:32 PM ET
Size
5.6 KB
Accession
0001225208-10-009458
Insider Transaction Report
Form 4
Stern Lawrence D
DirectorChairman & CEO
Transactions
- Tax Payment
Common Stock
2010-03-31$19.92/sh−127,448$2,538,764→ 1,202,102 total
Footnotes (1)
- [F1]The number of shares reported includes includes 186,600 shares that have not yet vested of the Issuer's common stock that were granted by the Issuer to the Reporting Person on July 25, 2007 and which will vest on March 31, 2011, subject to the Reporting Person remaining employed by the Issuer through that date, as detailed in a restricted stock award agreement by and between the Issuer and the Reporting Person, dated as of July 25, 2007. Also includes restricted share units representing the right to receive 45,366 shares of the Issuer's common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeother
Related Parties
1- filerCIK 0001472128
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:32 PM ET
- Size
- 5.6 KB